title: F-18 FDG PET/CT in rectal carcinoma: where are we now?
abstract: This short review aims at summarizing the available data pertaining to the usefulness of F-18 FDG PET/CT in rectal cancer. It is specifically focused on the emerging role of F-18 FDG PET/CT in assessing the response to neoadjuvant combined radiochemotherapy in locally advanced rectal cancer. It also probes the possibility of finding standardized PET/CT parameters that are capable of differentiating responders from nonresponders in whom therapeutic approach could be modified.
authors: Nuclear Medicine Department, PET-CT Centre, Santa Maria della Misericordia Hospital, Rovigo, Italy. gagra57@libero.it
authors: Gaia
authors: G
authors: Grassetto
authors: Maria Cristina
authors: MC
authors: Marzola
authors: Annamaria
authors: A
authors: Minicozzi
authors: Adil
authors: A
authors: Al-Nahhas
authors: Domenico
authors: D
authors: Rubello
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D064847:Multimodal Imaging; D049268:Positron-Emission Tomography; D012004:Rectal Neoplasms / Q000000981:diagnostic imaging*; D014057:Tomography, X-Ray Computed
chemical_list: D019788:Fluorodeoxyglucose F18